GOLD v LLN    Page 7


1. National Institutes of Health, National Heart, Lung and Blood Institute. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop Report. Update 2005.
2. Kerstjens HAM. The GOLD classification has not advanced understanding of COPD. Am J Resp Crit Care Med 2004; 170: 212-213.
3. National Institute for Health and Clinical Excellence (NICE). Summary of key priorities for implementation, algorithms and audit criteria. Thorax 2004; 59: 19-26. (
4. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
5. Quanjer PhH, Tammeling GJ, Cotes JE, et al. Lung volume and forced ventilatory flows. Report Working Party Standardization of lung function tests; Official Statement European Respiratory Society. Eur Respir J 1993; 6 Suppl 16: 15-40.
6. Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Morkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never smokers. Eur Respir J 2002; 20: 1117-1122.
7. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999; 159: 179-187.
8. Burrows B, Earle RH. Chronic obstructive lung disease. NEJM 1969; 280: 397-404.
9. Fletcher CM, Peto R, Tinker CM, Speizer FE. The Natural History of Chronic Bronchitis and Emphysema. Oxford University Press, 1976, pages 183-186. ISBN 0192611194.
10. Miller MR, Pedersen OF, Lange P, Vestbo J. Improved survival prediction from lung function data in a large population sample. Respir Med. 2009; 103: 442-8.
11. Miller MR, Pedersen OF, Dirksen A. Improved staging of chronic obstructive lung disease. Int J COPD 2007; 2: 657-663.
12. Miller MR and Pedersen OF. New concepts for expressing forced epxiratory volume in 1 s arising from survival analysis. Eur Respir J. 2010; 35: 873-82.